Asia Cervical Cancer Diagnostic Market Segmented By Test Type & Geography - Analysis & Forecast to 2024 - ResearchAndMarkets.com

DUBLIN--()--The "Asia Cervical Cancer Diagnostic Market, By Test Type (Pap smear, HPV DNA and VIA), Countries (Japan, Korea, Singapore, Malaysia, India, China, Thailand and Indonesia) & Forecast" report has been added to ResearchAndMarkets.com's offering.

Cervical cancer is the fourth most common cancer prevailing in women and the seventh in terms of overall cancer incidences. Cervical cancer diagnostic market in Asian region is growing and expected to cross over USD 1 Billion by 2024.

Cervical cancer affects the lower part of the uterus (womb). Cervical cancer generally occurs in women over 30 years. It is mostly caused by the Human papillomavirus (HPV) virus. Despite declining women population, Japan has the highest market share in cervical cancer test market. Whereas Indonesia is dominating in cervical cancer testing population followed by China.

Growing women population, rising sum of structured cervical cancer programs introduced by governments and international NGOs and inception of low cost VIA test are some of the major growth drivers for the growth of cervical cancer test market in the developing countries.

The report titled Asia Cervical Cancer Diagnostic Market, By Test Type (Pap smear, HPV DNA and VIA), Countries (Japan, Korea, Singapore, Malaysia, India, China, Thailand and Indonesia) & Forecast provides a complete analysis of Asia Cervical Cancer Screening Market. The report provides a complete analysis of Asia Countries Cervical Cancer Test Market, Screened Population & Mortality.

Country Coverage:

  • Japan
  • Korea
  • Singapore
  • Malaysia
  • India
  • China
  • Thailand
  • Indonesia

Key Topics Covered:

1. Executive Summary

2. Asia Cervical Cancer Test (Screening) Analysis

3. Market & Population Share - By Countries

4. Japan - Cervical Cancer Test Analysis

5. South Korea - Cervical Cancer Tests Analysis

6. Singapore - Cervical Cancer Tests Analysis

7. Malaysia - Cervical Cancer Test Analysis

8. India - Cervical Cancer Test Analysis

9. China - Cervical Cancer Test Analysis

10. Thailand - Cervical Cancer Test Analysis

11. Indonesia - Cervical Cancer Test Analysis

12. Growth Drivers

13. Challenges

For more information about this report visit https://www.researchandmarkets.com/research/8jfm9f/asia_cervical?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics, In Vitro Diagnostics

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics, In Vitro Diagnostics